Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.06 - Poster Session 1 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 59
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.06-051 - Development of a serum biomarker panel predicting clinical outcome of chemotherapy with pemetrexed in patients with NSCLC
09:30 - 09:30 | Author(s): J.A. Borgia
- Abstract
Loading... -
+
P1.06-052 - Biomarkers of phenotypic plasticity associated with clinical outcomes in patients with locally-advanced NSCLC treated with chemoradiation with and without surgery.
09:30 - 09:30 | Author(s): M. Batus
- Abstract
Loading...
-
+
P1.10 - Poster Session 1 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 57
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.10-036 - Prolongation of overall survival in non-small cell lung cancer before and after Food and Drug Administration (FDA) approval of active second line agents: a meta-analysis
09:30 - 09:30 | Author(s): M.J. Fidler
- Abstract
Loading...
-
+
P1.18 - Poster Session 1 - Pathology
- Type: Poster Session
- Track: Pathology
- Presentations: 22
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.18-012 - Thyroid transcription factor (TTF-1) negative lung adenocarcinomas will be wild type for epidermal growth factor receptor (EGFR) mutations.
09:30 - 09:30 | Author(s): M.J. Fidler
- Abstract
Loading...
-
+
O02 - NSCLC - Combined Modality Therapy I
- Type: Oral Abstract Session
- Track: Combined Modality
- Presentations: 8
- Moderators:W.E.E. Eberhardt
- Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Ballroom B, Level 1
-
+
O02.06 - Predictors of trimodality therapy use and overall survival in patients with stage III non-small cell lung cancer (NSCLC) in the National Cancer Database
11:25 - 11:35 | Author(s): M.J. Fidler
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.06 - Poster Session 3 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 53
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.06-051 - Circulating biomarkers may help guide selection of erlotinib versus chemotherapy in pretreated advanced NSCLC patients.
09:30 - 09:30 | Author(s): J.A. Borgia
- Abstract
Loading...
-
+
P3.10 - Poster Session 3 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 55
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.10-047 - Weight Gain During First-line Chemotherapy for Locally Advanced and Metastatic Non-Small-Cell Lung Cancer is Associated With Improved Survival
09:30 - 09:30 | Author(s): I. Ferreira
- Abstract
Loading...
